Navigation Links
Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
Date:2/12/2009

ated from the collaboration with Bayer, reimbursement of Onyx's shared marketing costs related to Nexavar and Nexavar royalty revenue. Onyx's 50% share of collaboration research and development expenses is included in the research and development expense line item.

In addition, all prior periods from January 1, 2006 through September 30, 2008 will be reclassified to conform to this new guidance and will be presented in Onyx's Form 8-K to be filed with the Securities and Exchange Commission prior to the fourth quarter and full year 2008 financial results call on February 23, 2009. For additional information on the structure of the company's new Statement of Operations, please visit the investor section of Onyx's website at http://www.onyx-pharm.com/wt/page/investors.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer, and other cancers. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
2. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results
3. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
4. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
5. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
6. Biotest Pharmaceuticals Corporation Acquires Santa Fe, New Mexico Plasmapheresis Center
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Par Pharmaceutical Announces Outcome of the Litigation With Pentech Pharmaceuticals
9. Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
10. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
11. Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
(Date:8/29/2014)... 30, 2014 Developed as a nod ... quality Canada Goose products offer the mobility, ... on Arctic runways. The company’s Canada Goose Chilliwack ... the current market. Additionally, the firm has unveiled its ... , At present, all high quality Chilliwack bombers ...
(Date:8/29/2014)... 29, 2014 As reported by GantDaily.com in ... Drug Abuse Trends , Outbreaks (8/20), the National Institute on ... monitor drug abuse trends by turning to social media. As ... trends, it is also working with the University of Maryland ... Early Warning System, which will be funded by the National ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Formed in 2014, ... talents well beyond their years. Their sophisticated Pop/R&B sound, ... music listener is fortunate enough to experience every day. ... their audience uplifted and feeling loved with the primary purpose ... specifically about this, the group unanimously replied - “To make ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... to Chapman University Physical Therapy students via Clinical ... Chapman University will be shadowing Healthpointe providers and ... allow them to develop clinical experience and learn ... Therapy students will gain insight into several patient ...
Breaking Medicine News(10 mins):Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2
... viruses due to their protective protein cover which protects them. ... //. ,Tackling this problem, scientists at the Institut ... the European Molecular Biology Laboratory (EMBL) in Grenoble have found ... a protein that allows the rabies virus to be harmful ...
... Australian beauty with roots in India open to acting in ... in India// who will represent Australia in the Miss World ... ,The first person of non-Australian parentage to win the ... an Indian mother and a Lebanese father. ,Sabrina, ...
... of Union Health Minister Anbumani Ramdoss, a pro-reservation ... P Venugopal and some senior doctors for allegedly ... Delhi against reservations for OBCs in higher education. ... members of the institution instigated the anti-quota protests ...
... According to a finding published in the medical journal Pediatrics, ... to guard// against chicken pox spurt in schools. ,Dr. ... Health conducted a study during an outbreak of chicken pox ... the 545 children attending the school had not suffered chicken ...
... in place of regular salt in everyday diet could ... , high blood pressure and diabetes, a study has ... Institutes in Taiwan and fellow researchers studied nearly 2,000 ... ,The researchers asked cooks at the retirement home to ...
... Swaraj today expressed concern over the turf war between Union ... saying it could "destroy the premier institution". ,"I am ... institution is being destroyed by the present union minister," she ... are working there and it is churning out the best ...
Cached Medicine News:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... , ... Netherlands , January 12 QIAGEN N.V.,(NASDAQ: QGEN ; ... GmbH, a privately held developer and manufacturer of UV and,fluorescence optical measurement ... at up to US$19 million in cash. , ...
... , MINNEAPOLIS, Jan. 11 ATS Medical, Inc. (Nasdaq: ... and services today announced preliminary fourth quarter 2009 revenue and ... Medical,s President and Chief Executive Officer, Michael Dale, at the ... 2010, in San Francisco, CA, at 8 a.m. Pacific Time ...
Cached Medicine Technology:QIAGEN Acquires ESE GmbH 2QIAGEN Acquires ESE GmbH 3QIAGEN Acquires ESE GmbH 4QIAGEN Acquires ESE GmbH 5QIAGEN Acquires ESE GmbH 6QIAGEN Acquires ESE GmbH 7ATS Medical Announces Preliminary Fourth Quarter 2009 Results 2ATS Medical Announces Preliminary Fourth Quarter 2009 Results 3ATS Medical Announces Preliminary Fourth Quarter 2009 Results 4
... QC 463 is a quality control ... monitoring the performance of blood gas, electrolyte, ... practical alternative to the use of human ... in three (3) levels for monitoring analyzer ...
Molteno3 Glaucoma Drainage Device incorporates the latest advances from Professor Moltenos glaucoma research. It has been extensively tested since early 2004 and gives even better control of intraocu...
... way to capture and process ultrasound images, ... a revolutionary advancement. The z.one platform, powered ... Convertible Ultrasound system, instantly converting from a ... ultrasound system with all the performance of ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: